Metropolitan Life Insurance Company (MetLife)’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,303	Closed	-$48K	–	2689
2016 Q3	$48K	Sell	2,303 -18,840	-89%	-$217K	﹤0.01%	2600
2016 Q2	$228K	Buy	+21,143	New	+$181K	﹤0.01%	2228
2016 Q1	–	Sell	-10,535	Closed	-$191K	–	2563
2015 Q4	$191K	Buy	10,535 +9,253	+722%	+$127K	﹤0.01%	2299
2015 Q3	$14K	Buy	+1,282	New	+$13.6K	﹤0.01%	2672

Metropolitan Life Insurance Company (MetLife)'s VTAE Position: Q4 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 2,303 shares — an estimated $48K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VTAE in Q3 2015 and held it in 4 quarters. The position peaked at $228K in Q2 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,303 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $48K.
Metropolitan Life Insurance Company (MetLife) first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2015 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $228K in Q2 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2016, filed 14 Feb 2017.